ESC Premium Access

Potent P2Y12 receptor inhibition – What can we learn from clinical practice?

Event: ESC CONGRESS 2016
Topic: Thrombosis and platelets
Session type: Satellite Symposium
Sponsored by Daiichi Sankyo Europe GmbH
Date: 28 August 2016
Time: 12:45 - 13:45

Session

4 presentations in this session

Welcome & introduction: Potent P2Y12 receptor inhibition – What can we learn from clinical practice?

Speaker: Professor K. Huber (Vienna, AT)
Thumbnail

How to apply guidelines to clinical practice.

Speaker: Professor A. Schaefer (Hannover, DE)
Thumbnail

Optimising P2Y12 inhibition in real world clinical practice: clinical outcomes of prasugrel and ticagrelor.

Speaker: Professor J. Jukema (Leiden, NL)
Thumbnail

Discussion – Summary and closing remarks: potent P2Y12 receptor inhibition – What can we learn from clinical practice?

Speaker: Professor K. Huber (Vienna, AT)
Thumbnail

4 speakers from this session

Professor Kurt Huber

Wilhelminen Hospital, Vienna (Austria)
40 presentations
6 followers

Professor Andreas Schaefer

Hannover Medical School, Hannover (Germany)
5 presentations
0 follower

Professor J Wouter Jukema

Leiden University Medical Centre, Leiden (Netherlands (The))
14 presentations
0 follower

Professor Kurt Huber

Wilhelminen Hospital, Vienna (Austria)
40 presentations
6 followers

This platform is supported by

logo Novo Nordisk